If the methodology of a full systematic review is not required or is too time consuming, evaluations can be tailored to the client’s needs.
Through close consultation we can provide minimum evaluations with accompanying selected validity tools or risk of bias evaluations. These assessments are less rigorous but still provide transparent evidence-based appraisals.
For clients interested in PDX cancer models we have existing validations for breast, colon, lung and prostate cancer xenografts. We can help match up the best validated cancer models for your needs.
We specialise in evaluations of the validity of preclinical models (human cell culture, organoids, 3D spheroids and patient derived xenografts), helping clients understand which are the best models for their needs.
Tailored evaluations take 1 week to 3 months to perform.